G0500822/MRC_/Medical Research Council/United Kingdom[Grants and Funding] - Search Results

Year	Number of Results
2007	3
2008	6
2009	4
2010	6
2011	4
2025	0

1

Targeting RNA to treat neuromuscular disease.

Muntoni F, Wood MJ. Muntoni F, et al. Nat Rev Drug Discov. 2011 Aug 1;10(8):621-37. doi: 10.1038/nrd3459. Nat Rev Drug Discov. 2011. PMID: 21804598 Review.

2

Modulating the expression of disease genes with RNA-based therapy.

Wood M, Yin H, McClorey G. Wood M, et al. PLoS Genet. 2007 Jun;3(6):e109. doi: 10.1371/journal.pgen.0030109. PLoS Genet. 2007. PMID: 17604456 Free PMC article. Review.

3

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.

Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K, Abbs S, Garralda ME, Bourke J, Wells DJ, Dickson G, Wood MJ, Wilton SD, Straub V, Kole R, Shrewsbury SB, Sewry C, Morgan JE, Bushby K, Muntoni F. Cirak S, et al. Lancet. 2011 Aug 13;378(9791):595-605. doi: 10.1016/S0140-6736(11)60756-3. Epub 2011 Jul 23. Lancet. 2011. PMID: 21784508 Free PMC article. Clinical Trial.

4

Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO.

Yin H, Moulton HM, Betts C, Merritt T, Seow Y, Ashraf S, Wang Q, Boutilier J, Wood MJ. Yin H, et al. Mol Ther. 2010 Oct;18(10):1822-9. doi: 10.1038/mt.2010.151. Epub 2010 Aug 10. Mol Ther. 2010. PMID: 20700113 Free PMC article.

5

Identification of a novel muscle targeting peptide in mdx mice.

Seow Y, Yin H, Wood MJ. Seow Y, et al. Peptides. 2010 Oct;31(10):1873-7. doi: 10.1016/j.peptides.2010.06.036. Epub 2010 Jul 17. Peptides. 2010. PMID: 20621144

6

D-amino acid oxidase knockdown in the mouse cerebellum reduces NR2A mRNA.

Burnet PW, Anderson PN, Chen L, Nikiforova N, Harrison PJ, Wood MJ. Burnet PW, et al. Mol Cell Neurosci. 2011 Jan;46(1):167-75. doi: 10.1016/j.mcn.2010.08.018. Epub 2010 Sep 7. Mol Cell Neurosci. 2011. PMID: 20828614

7

PNA-peptide conjugates as intracellular gene control agents.

Ivanova GD, Fabani MM, Arzumanov AA, Abes R, Yin H, Lebleu B, Wood M, Gait MJ. Ivanova GD, et al. Nucleic Acids Symp Ser (Oxf). 2008;(52):31-2. doi: 10.1093/nass/nrn016. Nucleic Acids Symp Ser (Oxf). 2008. PMID: 18776238

8

Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function.

Yin H, Moulton HM, Seow Y, Boyd C, Boutilier J, Iverson P, Wood MJ. Yin H, et al. Hum Mol Genet. 2008 Dec 15;17(24):3909-18. doi: 10.1093/hmg/ddn293. Epub 2008 Sep 10. Hum Mol Genet. 2008. PMID: 18784278 Free PMC article.

9

Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice.

Yin H, Lu Q, Wood M. Yin H, et al. Mol Ther. 2008 Jan;16(1):38-45. doi: 10.1038/sj.mt.6300329. Epub 2007 Oct 30. Mol Ther. 2008. PMID: 17968354 Free article.

10

Localization of double-stranded small interfering RNA to cytoplasmic processing bodies is Ago2 dependent and results in up-regulation of GW182 and Argonaute-2.

Jagannath A, Wood MJ. Jagannath A, et al. Mol Biol Cell. 2009 Jan;20(1):521-9. doi: 10.1091/mbc.e08-08-0796. Epub 2008 Oct 22. Mol Biol Cell. 2009. PMID: 18946079 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year